JW Pharmaceutical Corp
KRX:001060

Watchlist Manager
JW Pharmaceutical Corp Logo
JW Pharmaceutical Corp
KRX:001060
Watchlist
Price: 29 300 KRW 7.13% Market Closed
Market Cap: 698.5B KRW

Net Margin

7.8%
Current
Improving
by 1.4%
vs 3-y average of 6.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.8%
=
Net Income
₩59.3B
/
Revenue
₩764.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.8%
=
Net Income
₩59.3B
/
Revenue
₩764.2B

Peer Comparison

Country Company Market Cap Net
Margin
KR
JW Pharmaceutical Corp
KRX:001060
626B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
276.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
221.7B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
No Stocks Found

Market Distribution

Higher than 76% of companies in Korea
Percentile
76th
Based on 2 632 companies
76th percentile
7.8%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

JW Pharmaceutical Corp
Glance View

Market Cap
698.5B KRW
Industry
Pharmaceuticals

JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. The company is headquartered in Seoul, Seoul. The firm mainly produces and sells drugs including supplying protein amino acids in blood, blood and fluid substitutes, hyperlipidemia agents, electrolyte additives, angina pectoris agents, rheumatoid arthritis drugs, perfusion fluid, prostatic hypertrophy drugs, hepatic coma drugs, and iron injections, among others. The firm also researches and develops anticancer drugs.

JW Pharmaceutical Corp Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
7.8%
=
Net Income
₩59.3B
/
Revenue
₩764.2B
What is JW Pharmaceutical Corp's current Net Margin?

The current Net Margin for JW Pharmaceutical Corp is 7.8%, which is above its 3-year median of 6.3%.

How has Net Margin changed over time?

Over the last 3 years, JW Pharmaceutical Corp’s Net Margin has increased from 1.7% to 7.8%. During this period, it reached a low of 1.7% on Aug 30, 2022 and a high of 9.4% on Sep 30, 2024.

Back to Top